West Virginia Bill Could Empower Juries With More Relevant Evidence
Bill on seat belt admissibility heads to Governor
Gustavsen v. Alcon
(1st Circ., filed April 11, 2018): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendants had packaged it more efficiently does not describe a cognizable injury in fact, and therefore, they lack standing. Accepting plaintiffs’ theory would invite abusive class-action litigation.
On August 27, 2018, the court held that defendants could not change the drop size of an FDA-approved drug without prior FDA approval and thus that plaintiffs’ state-law claims were preempted.
Latest News
View all news
Brief Calls Out Joining Dissimilar Claims in Missouri Talc Suit
SCOTUS Determining Whether to Hear Appeal by Defendant
Florida Enacts Covid Liability Protections
Florida Governor Ron DeSantis signs covid liability protections into law in the state which has seen a disproportionate amount of legal services ads related to the COVID-19 pandemic.
Garland Should Oppose Biden Effort to Reinstate Controversial ‘Slush Funds’ Practice
Writing for The Hill, ATRA President Tiger Joyce discusses the Biden administration’s plans to allow a settlement slush fund and issues the practice has caused at the state level.
With This Missouri Case, the Supreme Court Could Curb Activist State Judiciaries
ATRA President Tiger Joyce writes about issues with a landmark talc case in Missouri and how the U.S. Supreme Court can step in.
West Virginia Legislature Looks to Address COVID-19 Liability
Trial lawyers’ spending on covid ads last year surpassed $260,000